Insider · CIK 0001022936

SANDERS CHARLES A

Reports to the SEC for 12 companies · DANBURY, CT

sec.gov

Transactions

Companies

Filings

CIK

0001022936

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-02-29	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+4,396 sh	$1.99	+$8,748.04	12,971
2015-11-30	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+824 sh	$10.61	+$8,742.64	8,575
2015-08-31	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+751 sh	$11.64	+$8,741.64	7,751
2015-05-20	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+15K sh	—	—	15,000
2013-05-31	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+15K sh	—	—	15,000
2013-01-30	LIPOSCIENCE INCSeries E Convertible Preferred StockC Conversion	Director	CConversion	−2,298 sh	—	—	0
2013-01-30	LIPOSCIENCE INCC Conversion	Director	CConversion	+1,114 sh	—	—	9,844
2012-05-23	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+15K sh	—	—	15,000
2012-03-13	BCRXBIOCRYST PHARMACEUTICALS INCP Purchase	Director	PPurchase	+2,000 sh	$5.21	+$10.4K	7,000
2012-03-13	BCRXBIOCRYST PHARMACEUTICALS INCP Purchase	Director	PPurchase	+2,000 sh	$5.20	+$10.4K	7,000
2012-03-08	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2011-09-30	ALBIREO PHARMA, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,937 sh	—	—	19,096
2011-09-30	ALBIREO PHARMA, INC.Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−3,937 sh	—	—	0
2011-09-02	ICAGEN INCU Disposition from Tender	Director	UDisposition from Tender	−25.7K sh	$6.00	−$154K	0
2011-09-01	ICAGEN INCDirector Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,750 sh	—	—	0
2011-09-01	ICAGEN INCDirector Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	0
2011-09-01	ICAGEN INCM Exercise/Conversion	Director	MExercise/Conversion	+3,750 sh	$3.36	+$12.6K	17,907
2011-09-01	ICAGEN INCDirector Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−3,750 sh	—	—	0
2011-09-01	ICAGEN INCM Exercise/Conversion	Director	MExercise/Conversion	+3,750 sh	$4.08	+$15.3K	21,657
2011-09-01	ICAGEN INCM Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	$2.56	+$10.2K	25,657
2011-08-10	ALBIREO PHARMA, INC.P Purchase	Director	PPurchase	+10K sh	$1.16	+$11.6K	15,159
2011-06-03	ICAGEN INCDirector Stock Option (right to buy)A Award	Director	AAward	+4,000 sh	—	—	4,000
2011-05-12	BCRXBIOCRYST PHARMACEUTICALS INC · Non-Qualified Stock OptionA Award	Director	AAward	+15K sh	—	—	15,000
2010-10-01	ALBIREO PHARMA, INC.Restricted Stock UnitsA Award	Director	AAward	+3,937 sh	—	—	3,937
2010-06-04	ICAGEN INCDirector Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2010-06-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionA Award	Director	AAward	+40K sh	—	—	40,000
2010-05-20	CEPHALON INCNon-Qualified Stock OptionA Award	Director	AAward	+15K sh	—	—	15,000
2010-05-13	BCRXBIOCRYST PHARMACEUTICALS INC · Non-Qualified Stock OptionA Award	Director	AAward	+15K sh	—	—	15,000
2010-05-11	ALBIREO PHARMA, INC.P Purchase	Director	PPurchase	+5,000 sh	$5.59	+$28K	5,159
2010-03-02	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2010-02-08	BCRXBIOCRYST PHARMACEUTICALS INCP Purchase	Director	PPurchase	+5,000 sh	$6.66	+$33.3K	5,000
2010-01-01	ICAGEN INCA Award	Director	AAward	+29.7K sh	—	—	113,261
2009-12-17	ICAGEN INCM Exercise/Conversion	Director	MExercise/Conversion	+2,396 sh	$0.50	+$1,198	83,537
2009-12-17	ICAGEN INCDirector Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	+2,396 sh	—	—	0
2009-12-08	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+8,333 sh	$6.70	+$55.8K	8,333
2009-06-03	ICAGEN INCDirector Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2009-06-01	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionA Award	Director	AAward	+40K sh	—	—	40,000
2009-05-18	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director	MExercise/Conversion	+3,333 sh	$10.05	+$33.5K	29,716
2009-05-18	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−3,333 sh	$28.44	−$94.8K	26,383
2009-05-18	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−3,333 sh	—	—	0
2009-05-12	CEPHALON INCNon-Qualified Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2009-05-11	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−3,333 sh	$30.41	−$101K	26,383
2009-05-11	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−3,333 sh	—	—	3,333
2009-05-11	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director	MExercise/Conversion	+3,333 sh	$10.05	+$33.5K	29,716
2009-05-04	VRTXVERTEX PHARMACEUTICALS INC / MAM Exercise/Conversion	Director	MExercise/Conversion	+3,334 sh	$10.05	+$33.5K	29,717
2009-05-04	VRTXVERTEX PHARMACEUTICALS INC / MA · Stock OptionM Exercise/Conversion	Director	MExercise/Conversion	−3,334 sh	—	—	6,666
2009-05-04	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	Director	SSale	−3,334 sh	$30.08	−$100K	26,383
2009-03-26	GENENTECH INCD Disposition to Issuer	Director	DDisposition to Issuer	−2,000 sh	$95.00	−$190K	0
2009-03-26	GENENTECH INCNon-Qualified Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2009-03-26	GENENTECH INCNon-Qualified Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−40K sh	—	—	0

Recent filings

Accepted (ET)
Mar 14
BIOCRYST PHARMACEUTICALS INC0001127602-16-044125
SEC(opens sec.gov)
Dec 34
BIOCRYST PHARMACEUTICALS INC0001127602-15-033172
SEC(opens sec.gov)
Sep 24
BIOCRYST PHARMACEUTICALS INC0001127602-15-026447
SEC(opens sec.gov)
May 224
BIOCRYST PHARMACEUTICALS INC0001127602-15-018283
SEC(opens sec.gov)
Jun 34
BIOCRYST PHARMACEUTICALS INC0001127602-13-019052
SEC(opens sec.gov)
Jan 304
LIPOSCIENCE INC0001209191-13-005166
SEC(opens sec.gov)
May 244
BIOCRYST PHARMACEUTICALS INC0001127602-12-018078
SEC(opens sec.gov)
Mar 154
BIOCRYST PHARMACEUTICALS INC0001127602-12-010719
SEC(opens sec.gov)
Mar 154/A
BIOCRYST PHARMACEUTICALS INC0001127602-12-010747
SEC(opens sec.gov)
Mar 94
Biodel Inc0001466049-12-000016
SEC(opens sec.gov)
Oct 44
Biodel Inc0001466049-11-000097
SEC(opens sec.gov)
Sep 74
ICAGEN INC0001209191-11-046939
SEC(opens sec.gov)
Sep 64
ICAGEN INC0001181431-11-048248
SEC(opens sec.gov)

Companies

Address

C/O BIODEL INC 100 SAW MILL ROAD

DANBURY, CT, 06810